PMC:7405836 / 64473-64741 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T584","span":{"begin":181,"end":185},"obj":"Disease"},{"id":"T585","span":{"begin":235,"end":243},"obj":"Disease"},{"id":"T586","span":{"begin":235,"end":239},"obj":"Disease"}],"attributes":[{"id":"A584","pred":"mondo_id","subj":"T584","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A585","pred":"mondo_id","subj":"T585","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A586","pred":"mondo_id","subj":"T586","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"Food and Drug Administration (FDA) had granted 22 in vitro diagnostics Emergency Use Authorizations (EUAs), including for the RT-PCR diagnostic panel for the universal detection of SARS-like betacoronaviruses and specific detection of SARS-CoV-2, developed by the U.S."}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T659","span":{"begin":47,"end":49},"obj":"http://purl.obolibrary.org/obo/CLO_0050507"}],"text":"Food and Drug Administration (FDA) had granted 22 in vitro diagnostics Emergency Use Authorizations (EUAs), including for the RT-PCR diagnostic panel for the universal detection of SARS-like betacoronaviruses and specific detection of SARS-CoV-2, developed by the U.S."}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T436","span":{"begin":0,"end":268},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Food and Drug Administration (FDA) had granted 22 in vitro diagnostics Emergency Use Authorizations (EUAs), including for the RT-PCR diagnostic panel for the universal detection of SARS-like betacoronaviruses and specific detection of SARS-CoV-2, developed by the U.S."}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"1967","span":{"begin":266,"end":267},"obj":"Gene"},{"id":"1972","span":{"begin":191,"end":208},"obj":"Species"},{"id":"1973","span":{"begin":235,"end":245},"obj":"Species"}],"attributes":[{"id":"A1967","pred":"tao:has_database_id","subj":"1967","obj":"Gene:43740568"},{"id":"A1972","pred":"tao:has_database_id","subj":"1972","obj":"Tax:694002"},{"id":"A1973","pred":"tao:has_database_id","subj":"1973","obj":"Tax:2697049"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Food and Drug Administration (FDA) had granted 22 in vitro diagnostics Emergency Use Authorizations (EUAs), including for the RT-PCR diagnostic panel for the universal detection of SARS-like betacoronaviruses and specific detection of SARS-CoV-2, developed by the U.S."}